THROMBI-PAD
Live / Registered — Registered and renewed (as of 20 Dec 2018)
What this means for you
Registered since 23 Dec 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Dec 2018).
Record
- Serial number
- 77103110
- Registration number
- 3550781
- Mark type
- Stylized text
- Filed
- 08 Feb 2007
- Published for opposition
- 19 Feb 2008
- Registered
- 23 Dec 2008
- Next maintenance due
- 23 Dec 2018
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical hemostatic agents in the nature of clotting pads
Owner
- KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, LLC, New York, NY, US
- King Pharmaceuticals Research and Development, Inc., Cary, NC, US
- King Pharmaceuticals Research and Development, Inc., Cary, NC, US
- King Pharmaceuticals Research and Development, Inc., Bristol, TN, US
Prior registrations
Prosecution history
- 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 Dec 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 20 Dec 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 20 Dec 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 20 Dec 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Dec 2018 — TEAS SECTION 8 & 9 RECEIVED
- 27 Dec 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP